{
    "id": "Asset_88",
    "name": "PTFQ_10: Warfarin to Cancer Neoplasia",
    "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
    "tags": [],
    "test_runner_settings": [
        "pathfinder"
    ],
    "source_input_id": "CHEBI:10033",
    "source_input_name": "Warfarin",
    "source_input_category": "biolink:SmallMolecule",
    "target_input_id": "MONDO:0004992",
    "target_input_name": "Cancer",
    "target_input_category": "biolink:Disease",
    "predicate_id": "biolink:related_to",
    "predicate_name": "related to",
    "qualifiers": null,
    "minimum_required_path_nodes": 2,
    "path_nodes": [
        {
            "ids": [
                "NCBIGene:79001"
            ],
            "name": "VKORC1"
        },
        {
            "ids": [
                "MESH:C021527"
            ],
            "name": "vitamin K oxidoreductase"
        },
        {
            "ids": [
                "NCBIGene:558"
            ],
            "name": "AXL"
        },
        {
            "ids": [
                "NCBIGene:2621"
            ],
            "name": "GAS6"
        },
        {
            "ids": [
                "CHEBI:28384"
            ],
            "name": "Vitamin K"
        },
        {
            "ids": [
                "GO:0001837, GO:0010717"
            ],
            "name": "Epthelial-to-Mesenchymal -transition"
        }
    ],
    "expected_output": "TopAnswer"
}